KR910009269A - 뇌기능을 증진시키기 위한 15-케토-프로스타글란딘 화합물의 용도 - Google Patents
뇌기능을 증진시키기 위한 15-케토-프로스타글란딘 화합물의 용도 Download PDFInfo
- Publication number
- KR910009269A KR910009269A KR1019900018959A KR900018959A KR910009269A KR 910009269 A KR910009269 A KR 910009269A KR 1019900018959 A KR1019900018959 A KR 1019900018959A KR 900018959 A KR900018959 A KR 900018959A KR 910009269 A KR910009269 A KR 910009269A
- Authority
- KR
- South Korea
- Prior art keywords
- keto
- prostaglandin compound
- compound
- composition
- prostaglandin
- Prior art date
Links
- 230000003925 brain function Effects 0.000 title claims 2
- 239000000203 mixture Substances 0.000 claims 10
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 150000002367 halogens Chemical class 0.000 claims 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (15)
15-케토-프로스타글란딘 화합물을 약제학적으로 허용가능한 담체, 희석제 또는 부형제와 함께 함유하는 뇌작용 증진을 위한 약제학적 조성물.
제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 16-모노- 또는 디-할로-15-케토-프로스타글란딘 화합물임을 특징으로 하는 조성물.
제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13,14-디히드로-16-모노-또는 디-할로-15-케토-프로스타글란딘 화합물임을 특징으로 하는 조성물.
제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13,14-디히드로-16-모노-또는 디-플루오로-15-케토-프로스타글란딘 화합물임을 특징으로 하는 조성물.
제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 6,15-디케토-프로스타글란딘 화합물임을 특징으로 하는 조성물.
제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13,14-디히드로- 6,15-디케토-프로스타글란딘 화합물임을 특징으로 하는 조성물.
제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 15-케토-19-알킬-프로스타글란딘 화합물임을 특징으로 하는 조성물.
제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13,14-디히드로-15-케토-19-알킬-프로스타글란딘 화합물임을 특징으로 하는 조성물.
제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13,14-디히드로-15-케토-19-메틸-프로스타글란딘 화합물임을 특징으로 하는 조성물.
제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 13,14-디히드로-6.15-디케토-5-모노 또는 디-할로-프로스타글란딘 화합물임을 특징으로 하는 조성물.
제1항에 있어서, 상기 15-케토-프로스타글란딘 화합물이 15-케토-프로스타글란딘 I 화합물임을 특징으로 하는 조성물.
하기 일반식(Ⅲ)의 화합물 또는 약제학적 허용염(Ra가 수소인 경우) :
상기식에서, Q1은 할로겐이고, Q2는 수소 또는 할로겐이며, E는 -CH2-CH2-또는 -CH=CH- 이고, Ra는 수소 또는 저급 알킬이며, Rb는 단일결합 또는 저급 알킬렌이고, Rc는 비치환되거나 할로겐으로 치환된 저급 알킬, 비치환되거나 저급 알킬로 치환된 저급 시클로알킬, 비치환되거나 할로겐 또는 할로(저급)알킬로 치환된 모노시클릭 아릴, 또는 비치환되거나 할로겐 또는 할로(저급)알킬로 치환된 모노시클릭 아릴옥시이다.
제12항에 있어서, Q1이 불소인 화합물.
제12항에 있어서, E가 -CH2-CH2- 인 화합물.
제12항에 있어서, Rb가 단일결합이고 Rc가 저급 알킬인 화합물.
※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019980005506A KR0167745B1 (ko) | 1989-11-22 | 1998-02-21 | 15-케토-프로스타글란딘 i 화합물을 함유하는 뇌기능 보호제 |
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP303839/89 | 1989-11-22 | ||
JP30383989 | 1989-11-22 | ||
JP761190 | 1990-01-17 | ||
JP1-303839 | 1990-01-17 | ||
JP90-7611 | 1990-01-17 | ||
JP7611/90 | 1990-01-17 | ||
JP8543990A JPH07116135B2 (ja) | 1990-03-30 | 1990-03-30 | 6,15―ジケト―5―ハロプロスタグランジンe類 |
JP85439/90 | 1990-03-30 | ||
JP90-85439 | 1990-03-30 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019980005506A Division KR0167745B1 (ko) | 1989-11-22 | 1998-02-21 | 15-케토-프로스타글란딘 i 화합물을 함유하는 뇌기능 보호제 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR910009269A true KR910009269A (ko) | 1991-06-28 |
KR0147057B1 KR0147057B1 (ko) | 1998-08-17 |
Family
ID=27277677
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900018959A KR0147057B1 (ko) | 1989-11-22 | 1990-11-22 | 뇌기능을 증진시키기 위한 15-케토-프로스타글란딘 화합물의 용도 |
KR1019980005506A KR0167745B1 (ko) | 1989-11-22 | 1998-02-21 | 15-케토-프로스타글란딘 i 화합물을 함유하는 뇌기능 보호제 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019980005506A KR0167745B1 (ko) | 1989-11-22 | 1998-02-21 | 15-케토-프로스타글란딘 i 화합물을 함유하는 뇌기능 보호제 |
Country Status (9)
Country | Link |
---|---|
US (3) | US5117042A (ko) |
EP (1) | EP0435443B1 (ko) |
KR (2) | KR0147057B1 (ko) |
AT (1) | ATE141793T1 (ko) |
CA (1) | CA2030345C (ko) |
DE (1) | DE69028289T2 (ko) |
DK (1) | DK0435443T3 (ko) |
ES (1) | ES2093636T3 (ko) |
GR (1) | GR3020902T3 (ko) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2851704B2 (ja) * | 1993-02-03 | 1999-01-27 | 帝人株式会社 | 脳血栓症治療のための薬学的組成物 |
HU223345B1 (hu) | 1995-12-20 | 2004-08-30 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára |
DE69714698T2 (de) * | 1996-06-10 | 2002-12-05 | Sucampo Ag | Endothelin-antagonisten |
CA2269855A1 (en) | 1996-11-12 | 1998-05-22 | Alcon Laboratories, Inc. | 15-fluoro prostaglandins as ocular hypotensives |
US6680339B2 (en) | 1996-11-12 | 2004-01-20 | Alcon Manufacturing, Ltd. | 15-fluoro prostaglandins as ocular hypotensives |
ID23971A (id) * | 1997-09-09 | 2000-06-14 | Procter & Gamble | Prostaglandin tetrahidro tersubstitusic c<16>-c<20> aromatik yang berguna sebagai agonis fp |
BR9812631A (pt) * | 1997-09-09 | 2000-08-22 | Procter & Gamble | Tetraidro prostaglandinas substituìdas por c16-c20 aromáticos úteis como agonistas de fp |
AU739343B2 (en) * | 1997-11-28 | 2001-10-11 | Sucampo Ag | Endothelin antagonist |
ES2232434T3 (es) | 1999-03-05 | 2005-06-01 | Duke University | Analogos de prostaglandinas c-16 fp selectivas insaturadas. |
JP4332316B2 (ja) * | 1999-10-15 | 2009-09-16 | スキャンポ・アーゲー | 二環式化合物組成物およびその安定化方法 |
KR100788226B1 (ko) * | 2000-03-24 | 2007-12-26 | 수캄포 아게 | 15-케토-프로스타글란딘 또는 이의 유도체를 포함하는세포자연사 억제 조성물 |
US20020172693A1 (en) * | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US20020037914A1 (en) * | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
US20020146439A1 (en) * | 2000-03-31 | 2002-10-10 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins |
US6414016B1 (en) | 2000-09-05 | 2002-07-02 | Sucampo, A.G. | Anti-constipation composition |
TWI331920B (en) | 2001-11-14 | 2010-10-21 | Sucampo Ag | Unit dosage form for relieving or treating constipation in human patients |
US7732487B2 (en) | 2001-11-19 | 2010-06-08 | Sucampo Ag | Method for treating a disease or condition responsive to opening of C1C-2 channel |
JP5147404B2 (ja) * | 2005-01-27 | 2013-02-20 | スキャンポ・アーゲー | 中枢神経系障害の処置のための方法および組成物 |
US20060281818A1 (en) * | 2005-03-21 | 2006-12-14 | Sucampo Ag, North Carolina State University | Method for treating mucosal disorders |
US20090082442A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched lubiprostone |
US8513441B2 (en) * | 2008-08-29 | 2013-08-20 | Alphora Research Inc. | Prostaglandin synthesis and intermediates for use therein |
US8623918B2 (en) * | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
WO2010083597A1 (en) | 2009-01-22 | 2010-07-29 | Apotex Pharmachem Inc. | Methods of making lubiprostone and intermediates thereof |
KR20140076551A (ko) | 2011-08-05 | 2014-06-20 | 수캄포 아게 | 정신분열증의 치료 방법 |
CN104140410B (zh) * | 2013-05-09 | 2017-12-15 | 江苏豪森药业集团有限公司 | 鲁比前列酮的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0153858A3 (en) * | 1984-02-29 | 1985-12-11 | The Upjohn Company | The therapeutic use of prostaglandins |
JPS62198616A (ja) * | 1986-02-24 | 1987-09-02 | Res Dev Corp Of Japan | 脳血流量改善・脳細胞保護剤 |
CA1322749C (en) * | 1987-01-28 | 1993-10-05 | Ryuzo Ueno | Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
CA1323364C (en) * | 1987-01-28 | 1993-10-19 | Ryuzo Ueno | Prostaglandins e and anti ulcer agents containing same |
CA1324129C (en) * | 1987-04-30 | 1993-11-09 | Ryuzo Ueno | Prostaglandins of the f series |
ES2038289T3 (es) * | 1987-05-15 | 1993-07-16 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal. |
ATE82499T1 (de) * | 1987-09-18 | 1992-12-15 | R Tech Ueno Ltd | Okulare hypotensivagenzien. |
ES2051862T3 (es) * | 1987-10-02 | 1994-07-01 | Ueno Seiyaku Oyo Kenkyujo Kk | Un metodo para producir un medicamento que tiene un efecto catartico. |
AU619543B2 (en) * | 1988-05-11 | 1992-01-30 | Sucampo Ag | Use of 15-ketoprostaglandin e or f compounds for uterine contraction |
JP2597649B2 (ja) * | 1988-05-11 | 1997-04-09 | 株式会社上野製薬応用研究所 | 気管・気管支拡張剤 |
EP0343904B1 (en) * | 1988-05-23 | 1993-04-28 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Hypersphyxia causing composition |
US5106809A (en) * | 1990-12-14 | 1992-04-21 | Exxon Research And Engineering Company | High activity, high yield tin modified platinum-iridium catalysts, and reforming process utilizing such catalysts |
-
1990
- 1990-11-20 CA CA002030345A patent/CA2030345C/en not_active Expired - Lifetime
- 1990-11-21 US US07/616,960 patent/US5117042A/en not_active Expired - Lifetime
- 1990-11-21 AT AT90312642T patent/ATE141793T1/de not_active IP Right Cessation
- 1990-11-21 DE DE69028289T patent/DE69028289T2/de not_active Expired - Lifetime
- 1990-11-21 EP EP90312642A patent/EP0435443B1/en not_active Expired - Lifetime
- 1990-11-21 ES ES90312642T patent/ES2093636T3/es not_active Expired - Lifetime
- 1990-11-21 DK DK90312642.3T patent/DK0435443T3/da active
- 1990-11-22 KR KR1019900018959A patent/KR0147057B1/ko not_active IP Right Cessation
-
1991
- 1991-10-16 US US07/777,595 patent/US5290811A/en not_active Expired - Lifetime
-
1993
- 1993-10-29 US US08/142,968 patent/US5426115A/en not_active Expired - Lifetime
-
1996
- 1996-08-29 GR GR960402122T patent/GR3020902T3/el unknown
-
1998
- 1998-02-21 KR KR1019980005506A patent/KR0167745B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0435443A3 (en) | 1993-01-27 |
US5117042A (en) | 1992-05-26 |
US5426115A (en) | 1995-06-20 |
EP0435443B1 (en) | 1996-08-28 |
KR0147057B1 (ko) | 1998-08-17 |
CA2030345A1 (en) | 1991-05-23 |
ATE141793T1 (de) | 1996-09-15 |
DE69028289T2 (de) | 1997-01-09 |
DE69028289D1 (de) | 1996-10-02 |
KR0167745B1 (ko) | 1999-01-15 |
EP0435443A2 (en) | 1991-07-03 |
GR3020902T3 (en) | 1996-11-30 |
DK0435443T3 (da) | 1996-09-16 |
US5290811A (en) | 1994-03-01 |
ES2093636T3 (es) | 1997-01-01 |
CA2030345C (en) | 1998-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR910009269A (ko) | 뇌기능을 증진시키기 위한 15-케토-프로스타글란딘 화합물의 용도 | |
CA2039420A1 (en) | Treatment of cataract with 15-keto-prostaglandin compounds | |
DE59010810D1 (de) | Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure | |
KR880012551A (ko) | 피페리딘 아편양 길항체 | |
NO892982D0 (no) | Tetrahydro-1-benz-(c,d)-indolpropionsyre-sulfonamider. | |
KR920002151A (ko) | 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료 | |
KR920703512A (ko) | 단백질 활성효소 c(protein kinase c)를 방해하는 1, 4-비스-(아미노-하이드록시알킬아미노)-안트라퀴논 | |
FR2436779A1 (fr) | Derives de pyrrolidine-2 methanol utilisables comme medicaments | |
KR910014380A (ko) | 이미자조피리다진 화합물, 그의 제법 및 용도 | |
KR890006639A (ko) | 벤조티아진 디옥사이드 유도체 | |
KR910007531A (ko) | 15-케토-프로스타글란딘 화합물을 이용한 간 담즙성 질병의 치료 | |
FR2646773B1 (fr) | Composition pharmaceutique a base de paracetamol | |
EP0347123A3 (en) | Dibenzo-cycloheptenyl, -cycloheptyl and -oxepinyl amines having antihistaminic properties | |
KR910009270A (ko) | 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법 | |
EP0383318A3 (en) | Aralkylamine compounds | |
KR910005860A (ko) | 항간질환성 조성물 | |
KR910006310A (ko) | 신규한 나프탈렌 및 테트라히드로 나프탈렌 치환된 겜-디포스포네이트 유도체 | |
KR920003972A (ko) | 프로스타시클린 화합물을 이용한 백내장 치료 | |
DE3769287D1 (de) | Heilmittel gegen leishmaniose. | |
DE69016266D1 (de) | Aminoketonverbindungen. | |
DK298889D0 (da) | (+)-1-oe(3,4,5-trimethoxy)benzyloxymethylaa-1-phenyl-n,n-dimethyl-n-propylamin samt laegemidler med indhold af denne forbindelse | |
KR880001628A (ko) | 비사이클릭 방향족 설포닐 클로라이드의 합성 | |
FR2637499A1 (fr) | Medicaments a base de nouveaux derives de la methoxycarbonyl-2 n, n'-di-(trimethoxybenzoyle) piperazine | |
KR920006354A (ko) | 피라졸로퀴놀린 유도체 | |
KR880000383A (ko) | 1,7-치환된 헵틴-2-온 및 신경성 방광질환 치료에 있어서의 그 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AMND | Amendment | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J2X1 | Appeal (before the patent court) |
Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL |
|
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20100401 Year of fee payment: 13 |
|
EXPY | Expiration of term |